With the integration of frog and Cambridge Consultants, Capgemini Invent now comprises a global team of 10,000 strategists, data scientists, product and experience designers, brand experts and technologists.
Helius Medical Technologies’ groundbreaking PoNS device for short-term treatment of gait deficit due to multiple sclerosis has received marketing authorization from the U.S. Food and Drug Administration (FDA).
Cambridge Consultants developed the ground-breaking optics technology powering Ellume’s FDA authorized COVID-19 Home Test
Cambridge Consultants adds new IP to Audio Weaver, pushes audio boundaries, brings decades of integrated systems expertise
Cambridge Consultants working in collaboration with World Mobile Stratospheric unveils a wireless antenna unlike anything seen before, delivering affordable 5G connectivity from a fleet of zero-emissions aircraft.
Cambridge Consultants & Kytopen announce the initial release of the Flowfect™ Tx System, a breakthrough that will help deliver the full promise of cell therapies to tackle disease.